by Benzinga Insights | Nov 13, 2026 | General
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 1.92% on an annualized basis producing an average annual return of 15.08%. Currently, ResMed has a market capitalization of $33.60 billion. Buying $100 In RMD: If an investor had bought $100 of...
by Piero Cingari | Nov 13, 2026 | General
For three years, Wall Street bought the artificial intelligence boom through one ticker. This week, it went shopping for substitutes. Nvidia Corp. (NASDAQ:NVDA) founder Jensen Huang resigned as CEO and board member Thursday after the board opened a probe into reports...
by Benzinga Insights | Nov 13, 2026 | General
Union Pacific (NYSE:UNP) has outperformed the market over the past 20 years by 5.02% on an annualized basis producing an average annual return of 13.78%. Currently, Union Pacific has a market capitalization of $180.72 billion. Buying $100 In UNP: If an investor had...
by Khyathi Dalal | Nov 13, 2026 | General
Bitcoin (CRYPTO: BTC) may be on track to finish in the red for a second straight year — and changing market cycles may be the explanation as to why that is. Bitcoin Magazine’s latest “Chart of the Day” analysis highlighted that Bitcoin ended 2025 down nearly 6% and...
by Benzinga Insights | Nov 13, 2026 | General
Cameco (NYSE:CCJ) has outperformed the market over the past 5 years by 12.01% on an annualized basis producing an average annual return of 21.92%. Currently, Cameco has a market capitalization of $31.26 billion. Buying $100 In CCJ: If an investor had bought $100 of...
Recent Comments